RETATRUTIDE 20 MG

Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors, potentially improving insulin sensitivity, reducing visceral adiposity and hepatic steatosis; mitochondrial repair and HDL-lowering effects